Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Johanna lahdenranta"'
Autor:
Jun Ma, Kristen Hurov, Johanna lahdenranta, Punit Upadhyaya, Elizabeth Repash, Julia Kristensson, Eric Haines, Kevin McDonnell, Philip Brandish, Nicholas Keen, Fanglei You, Mike Kelly, Heather Cohen, Drasti Kanakia, Carly Campbell, David Witty, Stephen Blakemore, Phil Jeffrey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/4724c01b9ec7407d90abf3570e647883
Autor:
Mate Nagy, Kristen Hurov, Johanna lahdenranta, Nicholas Keen, Dominic Smethurst, Qingyan Au, Heather Cohen, Carly Campbell, Stephen Blakemore, Tara Gelb, David Galbraith, Dan Rozelle, Erinn Parnell, Phil Brandish, Sebastien Hazard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/102a84b0e197487c962ac3bde6fc8f41
Autor:
Kristen Hurov, Johanna lahdenranta, Punit Upadhyaya, Phil Jeffrey, Hitesh Mistry, Fernando Ortega, Christophe Chassagnole
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/379d284c453b41a4b6783c643e4ce1aa
Autor:
Kristen Hurov, Johanna lahdenranta, Gemma Mudd, Punit Upadhyaya, Elizabeth Repash, Julia Kristensson, Kevin McDonnell, Philip Brandish, Nicholas Keen, Phil Jeffrey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6414f70ad96342768354adee2801717c
Autor:
Sailaja Battula, Kristen Hurov, Johanna lahdenranta, Gemma Mudd, Punit Upadhyaya, Elizabeth Repash, Julia Kristensson, Marianna Kleyman, Jessica Kublin, Liuhong Chen, Eric Haines, Kevin McDonnell, Philip Brandish, Nicholas Keen, Rachel Dods, Rachid Lani, Katerine Van Rietschoten, Tom Stephen, Fanglei You
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Background In contrast to immune checkpoint inhibitors, the use of antibodies as agonists of immune costimulatory receptors as cancer therapeutics has largely failed. We sought to address this problem using a new class of modular synthetic drugs, ter
Externí odkaz:
https://doaj.org/article/2beebb8f72534439867cc69dff340982
Autor:
Jun Ma, Sailaja Battula, Kristen Hurov, Johanna lahdenranta, Gemma Mudd, Punit Upadhyaya, Elizabeth Repash, Julia Kristensson, Marianna Kleyman, Jessica Kublin, Liuhong Chen, Eric Haines, Kevin McDonnell, Philip Brandish, Nicholas Keen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/6541410690f84d4cbbca57e8c0959953
Autor:
Daniel C Kirouac, Jinyan Du, Johanna Lahdenranta, Matthew D Onsum, Ulrik B Nielsen, Birgit Schoeberl, Charlotte F McDonagh
Publikováno v:
PLoS Computational Biology, Vol 12, Iss 4, p e1004827 (2016)
Understanding the molecular pathways by which oncogenes drive cancerous cell growth, and how dependence on such pathways varies between tumors could be highly valuable for the design of anti-cancer treatment strategies. In this work we study how depe
Externí odkaz:
https://doaj.org/article/31a32c2b6edf4eab836911f6779157c6
Autor:
Chandrajit P Raut, Yves Boucher, Dan G Duda, Jeffrey A Morgan, Richard Quek, Marek Ancukiewicz, Johanna Lahdenranta, J Paul Eder, George D Demetri, Rakesh K Jain
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e26331 (2012)
Sorafenib is a multi-targeted tyrosine kinase inhibitor with therapeutic efficacy in several malignancies. Sorafenib may exert its anti-neoplastic effect in part by altering vascular permeability and reducing intra-tumoral interstitial hypertension.
Externí odkaz:
https://doaj.org/article/60a28fac75ca4f6a85b43605694a62b8
Autor:
Marina Cardó-Vila, Amado J Zurita, Ricardo J Giordano, Jessica Sun, Roberto Rangel, Liliana Guzman-Rojas, Cristiane D Anobom, Ana P Valente, Fábio C L Almeida, Johanna Lahdenranta, Mikhail G Kolonin, Wadih Arap, Renata Pasqualini
Publikováno v:
PLoS ONE, Vol 3, Iss 10, p e3452 (2008)
Interleukin-11 (IL-11) is a pleiotropic cytokine approved by the FDA against chemotherapy-induced thrombocytopenia. From a combinatorial selection in a cancer patient, we isolated an IL-11-like peptide mapping to domain I of the IL-11 (sequence CGRRA
Externí odkaz:
https://doaj.org/article/312aff42208e4999b42e49e1ed95db38
Publikováno v:
PLoS Medicine, Vol 5, Iss 1, p e24 (2008)
Externí odkaz:
https://doaj.org/article/77c20978fd094e4e91c38bfc4f98a350